Blog - FZCO

17/12/2024
Blogs
9 Comments
Eminence

Are Project Managers Future Ready!?!

“Change in inevitable, and the disruption it causes often brings both inconvenience and opportunity”Robert ScobleDisruption as defined by Cambridge dictionary is an interruption in the usual way that a system, process, or event works.The pharmaceutical industry is undergoing significant disruption due to rapid technological advancements, evolving market demands, and changes in regulatory environments. These disruptions present challenges, but they also offer opportunities for…
Read More
28/10/2024
Blogs
1 Comment
Eminence

The Evolving Role of Quality Assurance in Drug Safety: A Pharmacist’s Perspective

Quality Assurance (QA) has become an integral aspect of pharmacy practice, particularly in drug safety. As the healthcare landscape evolves, pharmacists are increasingly tasked with ensuring that medications are used safely and effectively. This article examines the importance of QA in community pharmacies, outlines best practices for QA implementation, discusses the impact of technological advancements…
Read More
03/10/2024
Blogs
No Comments
Eminence

EMINENCE PLEDGE #CommitmentToQuality

Indian Pharma Industry Under Scrutiny: Join Eminence Group’s Pledge to Uphold Quality!In the wake of recent revelations, the Indian pharma industry—a cornerstone of global healthcare—finds itself facing a critical juncture. The August 2024 drug alert report from the CDSCO has flagged 53 widely-used medications, including Paracetamol and Pan-D, as "Not of Standard Quality" (NSQ). This…
Read More
26/09/2024
Blogs
No Comments
Eminence

Navigating PV Audits: Best Practices, Do’s and Don’ts for Success

Rajendra Kumar Kasi, Vice President and Global Head – Pharmacovigilance, Glenmark in conversation with Team Eminence Business MediaPharmacovigilance audits are vital to ensuring that pharmaceutical companies meet regulatory guidelines and, more importantly, protect patient safety. These audits ensure that companies follow rigorous protocols for detecting, assessing, and preventing adverse drug reactions. It was a pleasure…
Read More
19/09/2024
Blogs
No Comments
Eminence

September 2024 Nitrosamine Guidelines Update: What Indian Pharma Companies Need to Know Now

Guarding Against Nitrate Variability and Water Contamination: New Nitrosamine Guidelines Released In a move that’s shaking up the pharma industry, regulatory bodies worldwide have introduced stricter guidelines on nitrosamine impurities in medicinal products as of September 2024. Nitrosamines, known for their potential to increase cancer risks, can form during drug manufacturing or storage. With these…
Read More
09/09/2024
Blogs
No Comments
Eminence

Is AI the Future of Drug Safety? A Global Perspective on AI in Pharmacovigilance

Alina PanourgiaPharmacovigilance and Regulatory Compliance AdvisorComposite PharmaIs AI the ultimate answer to drug safety? As pharmacovigilance evolves to keep pace with the pharmaceutical industry, the rise of Artificial Intelligence is transforming how we monitor the safety of medicines. AI offers incredible potential by analysing vast amounts of safety data from health records, patient registries, and…
Read More
28/08/2024
Blogs
3 Comments
Eminence

Mastering Cross-Contamination Control in Pharma

A Narrative by AV Jayakumar, President – Corporate Quality Assurance, Ajanta PharmaIn the high-stakes world where every action of Indian pharma companies is closely watched, cross-contamination is a challenge that requires constant vigilance. As someone deeply entrenched in the industry, AV Jayakumar has first-hand experience of how easily contamination can compromise a product's integrity. During…
Read More
20/08/2024
Blogs
No Comments
Eminence

Guarding Against Glycol Contaminants: How Chromatography and Impurity Profiling are Shaping the Future of Drug Safety

Impurities have become a significant concern for the industry, particularly following recent discoveries of harmful contaminants in widely used drugs. The presence of Diethylene Glycol (DEG) and Ethylene Glycol (EG) in medicinal products has emerged as a critical issue, leading to global recalls and triggering more stringent regulations by agencies like the U.S. FDA. These…
Read More